Evolent Health (EVH) Tops Q1 EPS by 3c ; Offers Guidance

Evolent Health (NYSE: EVH) reported Q1 EPS of ($0.02), $0.03 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $496.25 million versus the consensus estimate of $534.01 million.

GUIDANCE:

Evolent Health sees FY2026 revenue of $2.4-2.6 billion, versus the consensus of $2.5 billion.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
• Nokia unveils agentic AI tools for telecom network automation
• Kepler Cheuvreux Upgrades Kone OYJ (KNEBV:FH) (KNYJY) to Buy